GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Other Gross PPE

Voluntis (XPAR:ALVTX) Other Gross PPE : €1.86 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Other Gross PPE?

Voluntis's Other Gross PPE for the quarter that ended in Jun. 2021 was €1.86 Mil.

Voluntis's quarterly Other Gross PPE increased from Jun. 2020 (€-2.01 Mil) to Dec. 2020 (€1.63 Mil) and increased from Dec. 2020 (€1.63 Mil) to Jun. 2021 (€1.86 Mil).

Voluntis's annual Other Gross PPE declined from Dec. 2018 (€1.27 Mil) to Dec. 2019 (€-2.02 Mil) but then increased from Dec. 2019 (€-2.02 Mil) to Dec. 2020 (€1.63 Mil).


Voluntis Other Gross PPE Historical Data

The historical data trend for Voluntis's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Other Gross PPE Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Other Gross PPE
0.28 1.43 1.27 -2.02 1.63

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.06 -2.02 -2.01 1.63 1.86

Voluntis Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines